studi
aim
explor
effect
mechan
h
cordata
vapor
extract
acut
lung
injuri
ali
rapid
pulmonari
fibrosi
rpf
appli
volatil
extract
hc
rpf
rat
model
analyz
effect
ali
rpf
use
hematoxylineosin
h
e
stain
routin
blood
test
cell
count
bronchoalveolar
lavag
fluid
balf
lactat
dehydrogenas
ldh
content
van
gieson
vg
stain
hydroxyprolin
hyp
content
drywet
weight
ratio
express
smad
analyz
use
elisa
immunohistochemistri
western
blot
method
activ
ingredi
hc
vapor
extract
analyz
use
ga
chromatographmass
spectromet
gcm
effect
activ
ingredi
hc
viabil
cell
detect
use
mtt
assay
activ
ingredi
hc
vapor
extract
includ
lbornyl
acet
methylnnonyl
keton
result
lung
h
e
stain
hyp
content
drywet
weight
ratio
vg
stain
suggest
hc
vapor
extract
repair
lung
injuri
reduc
rpf
dosedepend
manner
upregul
inhibit
pathway
vivo
vitro
could
inhibit
viabil
cell
also
dosedepend
inhibit
express
enhanc
express
hc
vapor
extract
inhibit
lpsinduc
rpf
upregul
inhibit
pathway
tradit
acut
lung
injuri
ali
caus
pneumonedema
matrix
lesion
rather
pulmonari
fibrosi
howev
common
characterist
new
diseas
sever
acut
respiratori
syndrom
sar
first
studi
avian
influenza
first
studi
swine
influenza
pandem
first
studi
suggest
ali
may
initi
patholog
acut
respiratori
distress
syndrom
ard
rapid
pulmonari
fibrosi
rpf
ali
import
lethal
factor
shortterm
acut
exacerb
idiopath
pulmonari
fibrosi
mechan
repair
remodel
acut
lung
injuri
recent
gain
much
attent
base
common
characterist
mechan
diseas
establish
new
rpf
model
could
induc
ali
via
lipopolysaccharid
lp
threehit
regimen
found
day
two
import
time
window
rpf
houttuynia
cordata
hc
grass
saururacea
h
cordata
thumb
promis
drug
treat
rpf
chines
health
depart
clinic
report
claim
hc
could
prevent
treat
sar
avian
influenza
hc
water
extract
immunomodulatori
antisar
activ
evidenc
abil
significantli
inhibit
sarscov
proteas
rnadepend
rna
polymeras
significantli
dosedepend
stimul
prolifer
mous
splenic
lymphocyt
increas
proport
cell
secret
hc
ethanol
extract
inhibit
express
intern
immunopharmacolog
migrat
tarcinduc
jurkat
cell
inject
hc
direct
inhibitori
effect
pseudorabi
herpesviru
prv
vitro
hc
shown
select
inhibitor
volatil
chemic
compon
hc
main
pharmacolog
activ
compon
therefor
volatil
extract
hc
might
altern
drug
treat
rpf
inject
hc
produc
volatil
extract
suspend
state
food
drug
administr
china
sfda
due
report
allerg
shock
howev
use
tween
adjuv
solut
hc
extract
might
primari
caus
report
allerg
shock
afterward
sfda
reapprov
use
hc
intramuscular
inject
strengthen
standard
product
qualiti
manag
improv
secur
research
hc
activ
ingredi
pharmacolog
mechan
indispens
lp
dexamethason
dex
purchas
sigma
st
loui
unit
state
hc
vapor
extract
enterpris
group
china
prepar
follow
fresh
hc
g
expos
steam
distil
forerun
liquid
ml
collect
redistil
g
sodium
chlorid
ad
redistil
liquid
ml
total
healthi
wistar
rat
g
half
male
half
femal
suppli
experiment
anim
center
guangzhou
univers
chines
medicin
randomli
alloc
group
control
group
n
lp
group
n
dex
group
n
group
receiv
high
dose
hc
hhc
group
mgkg
n
group
receiv
medium
dose
hc
mhc
group
mgkg
n
group
receiv
low
dose
hc
lhc
group
mgkg
n
experi
conduct
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
protocol
approv
committe
ethic
anim
experi
guangzhou
univers
chines
medicin
surgeri
perform
sodium
pentobarbit
anesthesia
effort
made
minim
suffer
detail
descript
model
publish
previous
first
rat
given
lp
mgkg
intratrach
h
lp
mgkg
given
intraperiton
h
later
lp
mg
kg
given
intratrach
two
acut
stage
develop
pulmonari
fibrosi
observ
day
day
rat
receiv
third
lp
administr
dex
mgkg
hc
administ
intraperiton
day
day
high
medium
low
dosag
hc
determin
basi
clinic
applic
adult
accord
fda
guidelin
industri
review
estim
safe
start
dose
clinic
trial
therapeut
adult
healthi
volunt
collect
sampl
test
began
day
h
complet
third
lp
administr
blood
lung
tissu
sampl
taken
day
rat
infus
paraformaldehyd
fix
tissu
middl
lobe
right
lung
embed
paraffin
slice
section
h
e
vg
stain
test
blood
sampl
bronchoalveolar
lavag
fluid
balf
cell
count
determin
lung
drywet
weight
blood
balf
sampl
right
basement
trunk
use
cell
count
lactat
dehydrogenas
ldh
test
sampl
analyz
laboratori
first
affili
hospit
guangzhou
univers
tradit
chines
medicin
serum
cytokin
analyz
use
enzymelink
immuneabsorb
assay
elisa
tissu
mg
wet
weight
locat
dri
constant
weight
dri
weight
obtain
dri
weight
subtract
wet
weight
indic
water
content
repres
level
inflamm
drywet
weight
ratio
lung
parenchyma
weight
ratio
repres
level
fibrosi
extract
total
protein
lung
preserv
proteas
inhibitor
calbiochem
western
blot
assay
wet
tissu
mg
middl
lobe
right
lung
use
determin
hydroxyprolon
hyp
content
use
alkalin
hydrolysi
kit
jiancheng
bioengin
nanj
china
express
plasma
rat
supernat
cell
line
investig
use
elisa
kit
zyme
invitrogen
usa
absorb
nm
analyz
use
elx
tm
absorb
micropl
reader
bio
tek
usa
endogen
peroxidas
extract
hydrogen
peroxid
h
min
section
block
block
buffer
bsa
triton
phosphatebuff
salin
min
sampl
incub
monoclon
receptor
antibodi
santa
cruz
usa
antibodi
abcam
cambridg
h
h
section
incub
secondari
antibodi
h
follow
incub
horseradish
peroxidas
hrp
label
vectastain
elit
abc
reagent
vector
laboratori
h
horseradish
peroxidas
bind
detect
diaminobenzidin
dab
h
extract
protein
sampl
lung
cell
line
separ
sdspage
acrylamid
transfer
onto
pvdf
membran
macm
h
membran
block
nonfat
milk
dissolv
mm
trishcl
ph
contain
mm
nacl
tween
tbst
membran
wash
tbst
incub
monoclon
receptor
santa
cruz
usa
abcam
cambridg
cell
signal
technolog
usa
sigma
usa
antibodi
h
final
membran
treat
hrpconjug
igg
sigma
usa
detect
enhanc
chemiluminesc
ecl
western
blot
substrat
pierc
biotechnolog
usa
supernat
hc
vapor
extract
analyz
use
agil
n
gcm
usa
equip
quartz
microcapillari
chromatograph
column
agil
j
w
scientif
extract
ml
cyclohexan
dehydr
alcohol
demulsif
gc
oven
temperatur
held
min
rais
held
min
injector
temperatur
flow
rate
carrier
ga
helium
mlmin
split
ratio
dilut
sampl
vv
ethyl
acet
inject
manual
split
mode
major
compon
hc
vapor
extract
identifi
coinject
standard
wherev
possibl
confirm
kovat
indic
use
wiley
v
nation
institut
standard
technolog
nist
gcm
librari
rel
concentr
compound
essenti
oil
quantifi
base
peak
area
integr
analysi
program
murin
macrophagelik
raw
embryon
fibroblast
cell
shanghai
institut
cell
biolog
chines
academi
scienc
shanghai
china
cultur
rpmi
medium
supplement
fetal
bovin
serum
fb
hyclon
logan
ut
uml
penicillin
mgml
streptomycin
atmospher
humidifi
co
confluenc
cell
wash
twice
subsequ
cultur
serumfre
optimemi
medium
invitrogen
carlsbad
ca
preincub
h
cell
cultur
stimul
lp
ngml
cotreat
hc
vapor
extract
activ
ingredi
detect
gcm
cell
viabil
determin
mtt
assay
level
inflammatori
cytokin
includ
determin
use
elisa
assay
data
analyz
sd
group
differ
group
analyz
factori
model
anova
follow
student
ttest
spss
softwar
statist
analysi
use
perform
analys
p
b
consid
statist
signific
h
e
stain
slide
examin
investig
experienc
pneumonia
patholog
major
decis
consid
final
supplement
tabl
supplement
fig
result
show
lp
group
larg
number
monocyt
neutrophil
alveolar
space
alveolar
inflammatori
exud
reduc
doseand
timedepend
manner
hc
group
result
suggest
hc
vapor
extract
reduc
ali
tabl
lymphocyt
ratio
blood
sampl
lp
group
decreas
day
return
level
control
group
day
compar
lp
group
dex
reduc
lymphocyt
ratio
significantli
p
b
howev
level
three
hc
group
significantli
higher
lp
dex
group
day
p
b
ratio
mononuclear
phagocyt
balf
fig
supplement
tabl
three
hc
group
day
day
significantli
higher
lp
dex
group
p
b
ratio
chang
dosedepend
manner
result
suggest
hc
vapor
extract
regul
lymphocyt
ratio
fig
c
supplement
tabl
ldh
level
treatment
group
significantli
lower
lp
group
pb
ldh
level
hc
group
lower
dex
group
day
result
suggest
hc
reduc
ali
fig
supplement
tabl
hyp
content
increas
significantli
lp
group
pb
day
day
day
day
repres
two
distinct
rpf
stage
hyp
content
hhc
group
significantli
lower
lp
dex
group
day
pb
indic
highdos
hc
vapor
extract
better
inhibitori
effect
later
rpf
stage
lung
drywet
weight
ratio
fig
supplement
tabl
pulmonari
fibrosi
inhibit
day
dosedepend
manner
hc
group
inhibit
significantli
hhc
group
result
suggest
hc
reduc
rpf
fig
lp
group
collagen
fiber
progress
deposit
alveolar
septum
day
pulmonari
consolid
found
day
fig
compar
lp
group
fiber
deposit
decreas
dex
group
fig
compar
dex
lp
group
fiber
deposit
decreas
significantli
mhc
hhc
group
day
fig
k
addit
decreas
fiber
deposist
alveolar
septum
consist
hhc
group
consist
fig
suggest
hc
vapor
extract
might
improv
alveolar
framework
enhanc
alveolar
ventil
result
suggest
hc
vapor
extract
reduc
rpf
dosedepend
manner
serum
elisa
result
show
express
decreas
rapidli
day
continu
declin
gradual
day
lp
group
fig
supplement
tabl
express
decreas
gradual
day
three
hc
group
smallest
declin
observ
hhc
group
three
hc
group
show
high
express
level
day
suggest
hc
vapor
extract
upregul
secret
day
find
consist
result
western
blot
fig
immunohistochemistri
supplement
fig
experi
support
result
cell
treat
hc
downstream
signal
molecul
western
blot
result
show
express
synchron
express
group
day
howev
synchroni
disrupt
day
express
hc
group
higher
lp
dex
group
day
express
hc
group
lower
lp
dex
group
day
fig
suggest
hc
might
inhibit
express
pathway
hc
vapor
extract
might
upregul
express
pathway
serum
elisa
result
fig
supplement
tabl
show
express
peak
day
group
consist
western
blot
result
western
blot
result
lung
tissu
fig
show
express
high
lp
dex
lhc
group
weak
mand
hhc
group
day
express
increas
day
decreas
day
group
express
fig
chang
along
express
signific
differ
express
hc
group
dex
group
suggest
hc
vapor
extract
affect
signal
similar
manner
dex
serum
elisa
result
show
express
increas
day
lp
group
fig
supplement
tabl
express
dex
group
dramat
persist
lower
lp
group
day
p
b
express
hc
group
increas
day
decreas
day
elisa
result
show
compar
lp
group
express
hc
group
decreas
dosedepend
manner
consist
western
blot
fig
immunohistochemistri
supplement
fig
result
result
indic
hc
inhibit
express
downstream
signal
molecul
western
blot
fig
immunohistochem
supplement
fig
result
show
chang
express
consist
chang
express
group
day
synergist
smad
western
blot
fig
immunohistochem
supplement
fig
result
show
day
express
high
level
group
signific
differ
among
group
lp
dex
group
express
high
day
suggest
contribut
first
rpf
stage
therefor
downregul
express
day
hc
group
might
import
molecular
mechan
hc
vapor
extract
inhibit
rpf
antagonist
smad
signal
western
blot
fig
immunohistochem
supplement
fig
result
show
express
higher
day
day
group
weak
lp
dex
group
day
howev
express
remain
high
hc
group
dosedepend
manner
suggest
hc
vapor
extract
upregul
test
three
group
hc
vapor
extract
use
gcm
fig
found
activ
ingredi
hc
vapor
extract
compos
lbornyl
acet
methylnnonyl
keton
hc
content
four
compon
stabl
across
group
account
total
amount
averag
content
contrast
compon
pulmonari
interstitium
broaden
significantli
number
collagen
fiber
increas
pulmonari
interstitium
restructur
lp
day
c
red
collagen
fiber
thicken
dramat
form
bunch
sheet
indic
pulmonari
fibrosi
dex
inhibit
inflamm
exud
dramat
day
e
collagen
fiber
alveolar
space
normal
alveoli
intact
fewer
inflammatori
cell
interstiti
space
alveolar
space
dex
day
f
g
pulmonari
interstitium
thicken
inflammatori
exud
alveolar
space
increas
interstiti
collagen
fiber
thicken
dex
day
h
interstiti
space
thicken
consolid
significantli
alveolar
space
narrow
hc
group
day
q
interstiti
space
normal
hc
day
n
pulmonari
interstiti
collagen
fiber
prolifer
persist
interstiti
space
thicken
lhc
group
day
l
number
interstiti
cell
increas
alveoli
narrow
mhc
hhc
group
p
interstiti
space
thicken
number
collagen
fiber
increas
significantli
alveoli
normal
present
smaller
quantiti
stabl
across
group
suggest
respons
main
pharmacolog
effect
therefor
choos
lbornyl
acet
methylnnonyl
keton
studi
potenti
pharmacolog
mechan
four
compon
report
propos
sodium
houttuyfon
sh
effect
compon
hc
thu
use
hc
posit
control
cell
typic
immun
fibroblast
cell
respect
two
import
cell
type
involv
damag
repair
observ
viabil
cell
h
h
h
treatment
hc
vapor
extract
hc
mgml
mgml
mgml
lbornyl
acet
methylnnonyl
keton
sh
h
lp
ngml
hc
vapor
extract
sh
inhibit
viabil
cell
lbornyl
acet
enhanc
viabil
significantli
dosedepend
fig
addit
hc
vapor
extract
lbornyl
acet
inhibit
viabil
cell
significantli
dosedepend
fig
also
observ
viabil
cell
h
h
treat
lp
without
treatment
lp
result
show
hc
vapor
extract
inhibit
viabil
cell
use
elisa
analyz
concentr
supernat
h
treatment
lp
fig
b
hc
upregul
express
lbornyl
acet
inhibit
significantli
dosedepend
hc
inhibit
express
sh
upregul
significantli
dosedepend
result
suggest
hc
vapor
extract
inhibit
enhanc
secret
cell
dosedepend
manner
investig
appli
volatil
extract
hc
rpf
rat
model
found
hc
could
repair
rpf
upregul
inhibit
pathway
moreov
found
volatil
compon
hc
vapor
extract
mainli
compos
lbornyl
acet
methylnnonyl
keton
hc
inhibit
viabil
cell
hc
inhibit
secret
enhanc
secret
cell
suggest
effect
might
contribut
result
observ
vivo
interestingli
lbornyl
acet
sh
divers
effect
cell
suggest
volatil
extract
hc
complic
mechan
action
affect
ali
rpf
recent
studi
found
activ
ingredi
hc
water
extract
lbornyl
acet
strong
antitumor
antiviru
antipneumonia
antipulmonari
fibrosi
effect
suggest
potenti
anticanc
agent
suppress
signal
lbornyl
acet
shown
inhibit
nitric
oxid
prostaglandin
product
lipopolysaccharid
lp
activ
macrophag
hc
water
extract
remark
improv
morpholog
appear
lung
bleomycintr
rat
exhibit
protect
effect
bleomycininduc
pulmonari
fibrosi
investig
found
dosedepend
enhanc
lbornyl
acet
opposit
effect
fig
hc
vapor
extract
inhibit
sh
fig
suggest
lbornyl
acet
sh
might
differ
pharmacolog
action
ali
afp
suggest
polar
might
necessari
condit
aliinduc
fibrosi
lp
group
observ
polar
express
decreas
consist
express
increas
consist
induc
rpf
period
day
constitut
first
stage
rpf
second
stage
rpf
day
hc
dex
show
obviou
differ
antiinflammatori
antifibrosi
effect
day
hc
show
better
antiinflammatori
antifibrosi
effect
dex
day
compar
dex
hc
appropri
improv
immun
stress
statu
upregul
lympocytesmononuclear
phagocyt
ratio
day
might
advantag
fig
b
cytokin
multipl
function
proinflammatori
antivir
antifibrosi
effect
inhibit
influenza
viru
type
sarscov
replic
vitro
suggest
upregul
may
increas
surviv
sar
patient
express
declin
lp
group
suggest
immun
system
suppress
induc
rpf
hc
vapor
extract
increas
express
day
result
cell
show
might
activ
ingredi
hc
vapor
extract
upregul
express
hcinduc
upregul
express
accompani
upregul
express
suggest
hc
vapor
extract
might
inhibit
proinflammatori
pathway
thu
upregul
might
import
mechan
hc
reduc
rpf
cytokin
multipl
function
play
import
role
pulmonari
fibrosi
ali
inhibit
inflamm
improv
repair
rpf
upregul
prompt
fibrosi
suggest
involv
crucial
molecular
mechan
rpf
investig
hc
vapor
extract
inhibit
signal
via
